In the Lab
By Julie Grisham, MS, Science Writer/Editor | Friday, July 6, 2012
A team of investigators from Memorial Sloan Kettering has shown for the first time that tumor growth, metastasis, and chemotherapy resistance are connected to the same molecular changes inside breast cancer cells.
By Memorial Sloan Kettering | Monday, June 25, 2012
Dr. Morrow, Chief of Memorial Sloan Kettering’s Breast Surgical Service, discusses how our patients with breast cancer are cared for by a true team of experts in every aspect of treatment and recovery.
By Memorial Sloan Kettering | Friday, June 15, 2012
Dr. Bains talks about how he and other internationally recognized cancer experts work together to treat patients and help them return to their everyday activities.
In the News
By Media Staff | Tuesday, June 12, 2012
The magazine’s 15th annual issue recognizes more cancer physicians from Memorial Sloan Kettering than any other hospital.
By Memorial Sloan Kettering | Thursday, June 7, 2012
Dr. Allen talks about the specialized team of cancer experts at Memorial Sloan Kettering and the long-term relationships he maintains with his patients.
In the Clinic
By Media Staff | Monday, June 4, 2012
A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.
By Memorial Sloan Kettering | Friday, June 1, 2012
Memorial Sloan Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.
By Memorial Sloan Kettering | Tuesday, May 29, 2012
Dr. Pusic, a plastic surgeon specializing in breast reconstruction, talks about advances in reconstructive surgery techniques and in measuring quality of life for patients after surgery.
By Allyson Collins, MS, Science Writer/Editor | Monday, May 21, 2012
In an interview, Dr. Bach talks about research showing that CT screening may prevent one in five cancer deaths for people at a very high risk of developing lung cancer.
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor | Monday, May 21, 2012
Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.
By Media Staff | Thursday, May 17, 2012
Memorial Sloan Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.
By Memorial Sloan Kettering | Monday, May 14, 2012
Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.
By Memorial Sloan Kettering | Monday, May 7, 2012
Dr. Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan Kettering, a high-volume center.
By Memorial Sloan Kettering | Thursday, May 3, 2012
Dr. Rusch, Chief of the Thoracic Service, discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan Kettering.
By Memorial Sloan Kettering | Friday, April 27, 2012
Dr. Van Zee discusses the personalized care delivered by a multidisciplinary team of breast cancer experts at Memorial Sloan Kettering.